Nitroderm TTS 5
Nitroderm TTS 5 is a medicine authorised by Swissmedic under authorisation number 44192. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 December 1981 and the authorisation is valid without a time limit. ATC code C01DA02 places the medicine in the group Cardiac therapy.
| Authorisation number | 44192 |
|---|---|
| Name | Nitroderm TTS 5 |
| Full name | Nitroderm TTS 5, transdermales Pflaster |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01DA02 |
| First authorisation | 07 December 1981 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nitroderm TTS 5, transdermales Pflaster | B | 07 December 1981 |
| 2 | Nitroderm TTS 10, transdermales Pflaster | B | 07 December 1981 |
| 3 | Nitroderm TTS 15, transdermales Pflaster | B | 20 June 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 12 | 10 | Pflaster | C01DA02 | 02.04.1. | B |
| 20 | 30 | Pflaster | C01DA02 | 02.04.1. | B |
| 39 | 100 | Pflaster | C01DA02 | 02.04.1. | B |
| 47 | 10 | Pflaster | C01DA02 | 02.04.1. | B |
| 55 | 30 | Pflaster | C01DA02 | 02.04.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nitroderm TTS 5 authorised in Switzerland?
Yes. Nitroderm TTS 5 is authorised by Swissmedic under authorisation number 44192, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nitroderm TTS 5 have?
Nitroderm TTS 5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nitroderm TTS 5?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.